Anticoagulation valvular - RxFiles

RxFiles www.RxFiles.ca April Q&A Summary BSP, MSc

RxFiles Q&A Summary www.RxFiles.ca ‐ April 2012 Lynette Kosar BSP, MSc Are Antidepressants Safe during Pregnancy & Breastfeeding? Up to ~25% of pregnant women will suffer from depression while pregnant.1 The decision on how to treat depression and/or anxiety

  Summary, April, Antidepressant, Rxfiles, Ca april

SUBSTANCE ABUSE: Overview and Treatment …

SUBSTANCE ABUSE: Overview and Treatment Considerations ... Use, ...

  Abuse, Substance, Substance abuse

CANNABINOIDS Drug Comparison Chart 1,2 - RxFiles

CANNABINOIDS: Drug 1,2Comparison Chart L Regier BSP BA, B Jensen BSP © www.RxFiles.ca June 2017

  Chart, Comparison, Drug, Cannabinoids drug comparison chart, Cannabinoids

NSAIDS - DARE TO COMPARE - RxFiles

NSAIDs DARE TO COMPARE TheRxFiles July 1997 v Produced by the Community Drug Utilization Program, a Saskatoon District Health/St. Paul's Hospital program funded by Saskatchewan Health. For more information check

  Read, Nsaids dare to compare, Nsaids, Compare

RXFILES TRIAL SUMMARY O P B LK N 2012 F …

RXFILES TRIAL SUMMARY ORIGINALLY PREPARED BY:M JIN, REVISED LKOSAR –UPDATED NOV 2012 WWW.RXFILES.CA Page 1 of 3 ARISTOTLE: Apixaban vs Warfarin in patients with Atrial Fibrillation 1

  2012, Summary, Trail, Rxfiles, Rxfiles trial summary o p b lk n 2012 f, Rxfiles trial summary, Aristotle

QT PROLONGATION and TORSADES DE POINTES: …

The Rx Files: Q&A Summary Mar, 2005 S. Downey BSP, B. Jensen BSP, L.Regier BSP, BA PROMOTING OPTIMAL DRUG THERAPY www.RxFiles.ca QT PROLONGATION and TORSADES DE POINTES: DRUGS and SUDDEN DEATH

  Drug, Prolongation, Qt prolongation and torsades de pointes, Torsades, Pointes

RxFiles Q&A Summary

RxFiles: Q&A Summary www.RxFiles.ca ‐ Oct 2013 Debbie Bunka Chronic Insomnia in Older Adults Sleep patterns naturally change as one gets older.

RxFiles Krahn UofS Regier URGENCY …

RxFiles Q&A Summary www.RxFiles.ca ‐ updated June 2016 K Krahn UofS BSP Student 2014, L Regier BSP, BA HYPERTENSIVE URGENCY(ASYMPTOMATIC SEVERE HYPERTENSION): CONSIDERATIONS FOR MANAGEMENT

  Considerations, Severe, Hypertension, Hypertensive, Asymptomatic severe hypertension, Asymptomatic, Considerations for

Calcium Channel Blockers

Calcium Channel Blockers December 1997ii Calcium Channel Blockers (CCBs) are used in thetreatment of many cardiovascular conditions. Although they have generally been effective and well tolerated,

  Channel, Calcium, Calcium channel

Type 2 Diabetes (T2DM) - RxFiles

RxFiles Academic Detailing Service Saskatoon City Hospital, 701 Queen Street, Saskatoon, SK S7K 0M7 www.RxFiles.ca Overview of the …

NON-VITAMIN K ORAL ANTICOAGULANT REVERSAL

2 Approved 02/06/2013 Revised 02/03/2015 (aPTT), and ecarin clotting time (ECT) (1). Monitoring of anticoagulant activity can be performed using PT and aPTT levels, however, the relation is nonlinear with plasma drug concentration making utilization

  Monitoring, Anticoagulant, Reversal, Anticoagulant reversal

Anticoagulants and antiplatelet drugs - jaiser.com

1/8 Anticoagulants and antiplatelet drugs Classification Anticoagulants Parenteral Heparin UFH LMWH Enoxaparin Tinzaparin Dalteparin Certoparin

  Drug, Anticoagulant, Antiplatelet, Anticoagulants and antiplatelet drugs

Comparison between New Oral Anticoagulants and Warfarin

Comparison between New Oral Anticoagulants and Warfarin Warfarin was the mainstay of oral anticoagulant therapy until the recent discovery of more precise

  Comparison, Between, Oral, Anticoagulant, Comparison between new oral anticoagulants

NEW ORAL ANTICOAGULANTS FOR VENOUS …

NEW ORAL ANTICOAGULANTS FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS IN THE FOOT AND ANKLE Matthew Q. McCammon, DPM INTRODUCTION Venous thromboembolism (VTE) is a common cause of

  Oral, Anticoagulant, Venous, Thromboembolism, Prophylaxis, Oral anticoagulants for venous, Oral anticoagulants for venous thromboembolism prophylaxis

NON-VITAMIN K ORAL ANTICOAGULANT REVERSAL

3 Approved 02/06/2013 Revised 02/03/2015, 03/29/2016 Specific Reversal Agents (Antidotes) Dabigatran Idarucizumab is a monoclonal antibody fragment that binds specifically to dabigatran at a …

  Reversal, Dabigatran

Reversing the New Anticoagulants - UCSF CME

11/6/2013 4 Roadmap for today • Characteristics of novel anticoagulants • Approach to the bleeding patient • Specific reversal agents • UCSF Guidelines New Anticoagulants • Dabigatran (Pradaxa ®) • Rivaroxaban (Xarelto ®) • Apixaban (Eliquis®) New Anticoagulants • Dabigatran (Pradaxa ®) • Rivaroxaban (Xarelto ®) • Apixaban (Eliquis®) Dabigatran Indications

  Anticoagulant, Reversing, Reversal, Pradaxa, Dabigatran, Reversing the new anticoagulants